Larry Harshyne

6PUBLICATIONS

77CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSpeciation and extinction

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 03, 2026

Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

|Dec 12, 2025

Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.

Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson

|Sep 11, 2025

Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Nov 25, 2024

Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Oct 10, 2024

Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.

Priyan Bhattacharya, Alban Linnenbach, Andrew P South

|Mar 09, 2021

Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts.

Michael Prosniak, Larry A Harshyne, Jonathan Gorky

Pageof 1

Frequent Collaborators

Adam J Luginbuhl

Athanassios Argiris

Mỹ G Mahoney

Joseph M Curry

Jennifer M Johnson

Madalina Tuluc

Kathryn Nunes

Alban Linnenbach

Andrew P South

Ubaldo Martinez-Outschoorn

Frequent Collaborators

Adam J Luginbuhl

Athanassios Argiris

Mỹ G Mahoney

Joseph M Curry